
Pharmaceutical company.
Director, US Market Access Pipeline, Immunology at AbbVie
About the role
The U.S. healthcare system is complex. For Abb Vie to lead the industry in this environment, it is vital that our US Market Access (USMAx) Pipeline Team thoroughly comprehend the current and future state of the evolving U.S. healthcare space and market access channels.
The Director, USMAx Pipeline is an individual contributor who will lead U.S. market access strategy development for early pipeline priority assets within Immunology. This Director will be directly responsible for integrating an understanding of the complex U.S. health system and the needs and requirements of U.S. payers into early asset development and bring the voice of U.S. payers to our early drug development process. The ideal candidate will have a strong understanding of U.S. private and public payer segments, pharmacy and medical benefit reimbursement, buy and bill models, and the IRA. The candidate must be able to think strategically and critically, build strong and trusting relationships for cross-functional influence, and demonstrate strong executive presence in order to represent U.S. Market Access effectively in pipeline governance and business development discussions.
The Director will work closely with cross-functional colleagues in Pipeline Commercialization Strategy (PCS) and Commercial Leadership to determine USMAx project and deliverable prioritization and will lead the delivery of these projects. This role will ensure integration within the Abb Vie Pipeline Commercialization Model, including co-leadership of the Value and Access Teams (VATs) with International Market Access (IMAP) colleagues, and will lead the creation of US EIVPs (Early Integrated Value Propositions) and US Market Access Strategies. The Director will also participate in Asset Strategy Team discussions and provide leadership within other Pipeline Commercialization Model teams as needed (IEST). The ideal candidate will bring a proven track record of supporting a positive team culture, leading by example, strong cross-functional stakeholder alignment, and an understanding of the Abb Vie Pipeline Commercialization Model.
**Specific Accountabilities Include:
- Responsible and accountable for the access point of view and creation of Integrated Asset Strategies, Early Integrated Value Propositions and Disease Area Strategies within the Abb Vie Portfolio.
- Collaborate with teams across BUs, PCS, IMAP, Medical, HEOR, CBSO, IRA, R&D, and others to ensure the value drivers of USMAx decision makers are incorporated into pipeline commercialization strategies.
- Inform clinical development programs so that endpoints and evidence generation plans (i.e., clinical, economic, and humanistic outcomes) support optimized patient access for new and novel therapies
- Ensure project resource needs are met; secure and allocate budgets across asset assignments to meet critical enterprise goals for pipeline assets.
- Ensure that deep USMAx insights are embedded in all early pipeline strategies to support optimal asset development through the 1-7-5 model.
- Initiate market shaping in a timely fashion, ensuring a smooth hand-off to Directors, USMAx Marketing, for U.S. launch readiness preparation.
- Provide strong asset leadership, serving as the primary point of contact for USMAx Pipeline stakeholders aligned to that asset and disease area.
- Act as a critical partner to key internal stakeholders who drive early pipeline strategy, including U.S. Commercial Leadership, Asset Strategy Leadership, Pipeline Commercial Strategy Leadership, Medical Affairs/HEOR, and International Market Access and Pricing.
- Represent USMAx Early Pipeline as a subject matter expert at governance reviews as needed (e.g., TASC, LMG, DRC, etc.).
- Contribute critical strategic thinking to inform access and pricing assumptions to create accurate, market-driven LRP assumptions for pipeline assets and business development (as assigned).
- Serve as pipeline lead, accountable for USMAx financial LRP and strategic LRP assumptions for all assigned assets.
- Work closely across USMAx teams and stay up to date on channel dynamics and priorities.
- Partner with IRA and cross-strategy teams to ensure optimal asset planning and inform strategic planning and decision-making.
- Demonstrate enterprise mindset and leadership, act as a role model and example across the team
- Bachelor’s degree required.
- Proven ability to influence without authority and navigate complex and ambiguous organizational dynamics with sound decision-making.
- Subject matter expertise relevant to commercial and government payers is required.
- U.S. market access experience across several roles is preferred.
- Expertise in developing compelling early payer value propositions preferred.
- Experience leading primary and secondary payer research projects to inform payer insights, market value drivers, and channel strategies.
- Knowledge of government contracting, acquisition trends, and role of market access stakeholders across the patient journey
- Experience in pipeline development and/or market access launches, ideally in the assigned disease area.
- Experience with pharmacy and medical benefit products, pricing, and GtN (Gross-to-Net) influences as well as differing acquisition models (e.g., Buy & Bill, DTP).
- Previous disease area experience and knowledge of competitive environment as well as and clinical trial endpoints is preferred.
- Strong strategic thinking, communication skills, and executive presence are required.
- Financial acumen and ability to comprehend complex planning scenarios required.
Applicable only to applicants applying to a position in any location with pay disclosure requirements under state or local law:
-
The compensation range described below is the range of possible base pay compensation that the Company believes in good faith it will pay for this role at the time of this posting based on the job grade for this position. Individual compensation paid within this range will depend on many factors including geographic location, and we may ultimately pay more or less than the posted range. This range may be modified in the future.
-
We offer a comprehensive package of benefits including paid time off (vacation, holidays, sick), medical/dental/vision insurance and 401(k) to eligible employees.
-
This job is eligible to participate in our short-term incentive programs.
Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable. The amount and availability of any bonus, commission, incentive, benefits, or any other form of compensation and benefits that are allocable to a particular employee remains in the Company's sole and absolute discretion unless and until paid and may be modified at the Company’s sole and absolute discretion, consistent with applicable law.
Abb Vie is an equal opportunity employer and is committed to operating with integrity, driving innovation, transforming lives and serving our community. Equal Opportunity Employer/Veterans/Disabled.
US & Puerto Rico only - to learn more, visit https://www.abbvie.com/join-us/equal-employment-opportunity-employer.html
US & Puerto Rico applicants seeking a reasonable accommodation, click here to learn more:
https://www.abbvie.com/join-us/reasonable-accommodations.html
About Abb Vie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Required skills
Market access
Payer strategy
Commercialization planning
Strategic analysis
Stakeholder management
Healthcare reimbursement
Business development support
Cross-functional leadership
Total Views
0
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
More open roles at AbbVie

Sample Pull QA Technician ( 12 month FTC)
AbbVie · Westport

Production Operator ( 12 month FTC)
AbbVie · Cork

Training Co-Ordinator ( 12 month FTC)
AbbVie · Cork

Project Excellence Manager (all genders) (Vollzeit / unbefristet)
AbbVie · Wiesbaden

Sales Representative - Oncología - Ciudad de México
AbbVie · Mexico City
Similar jobs

Product Marketing Specialist
Stanley Black & Decker · Whitehorse, Melbourne, Australia

Sr. Category Manager (BLACK + DECKER)
Stanley Black & Decker · Maidenhead, Berkshire, England

Director, STANLEY Brand Commercialization, North America
Stanley Black & Decker · Towson, MD, United States

Global Product Marketer
3M · US, Minnesota, Maplewood

Product Marketing Manager
Cardinal Health · Canada-Vaughan
About AbbVie

AbbVie
PublicPharmaceutical company.
10,001+
Employees
North Chicago
Headquarters
$200B
Valuation
Reviews
10 reviews
3.6
10 reviews
Work-life balance
3.2
Compensation
4.1
Culture
4.0
Career
2.8
Management
2.9
68%
Recommend to a friend
Pros
Great benefits
Good compensation/salary
Flexible work arrangements
Cons
Heavy workload/long hours
Limited career advancement
Poor management/lack of direction
Salary Ranges
88 data points
Junior/L3
Mid/L4
Director
Junior/L3 · Associate Manager, Promotion Analytics
1 reports
$144,943
total per year
Base
$125,951
Stock
-
Bonus
-
$144,943
$144,943
Interview experience
4 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Experience
Positive 0%
Neutral 25%
Negative 75%
Interview process
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Offer
Common questions
Behavioral/STAR
Past Experience
Culture Fit
Technical Knowledge
Latest updates
AbbVie beats Q1 2026 earnings, raises full-year forecast - qz.com
qz.com
News
·
1w ago
AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline - Reuters
Reuters
News
·
1w ago
AbbVie Hikes Earnings Outlook As Immunology Duo Outperforms - Investor's Business Daily
Investor's Business Daily
News
·
1w ago
AbbVie files Rinvoq for alopecia areata with Phase III win - The Pharma Letter
The Pharma Letter
News
·
1w ago